109 related articles for article (PubMed ID: 19739612)
1. Identification of protein clusters predictive of response to chemotherapy in breast cancer patients.
Cortesi L; Barchetti A; De Matteis E; Rossi E; Della Casa L; Marcheselli L; Tazzioli G; Lazzaretti MG; Ficarra G; Federico M; Iannone A
J Proteome Res; 2009 Nov; 8(11):4916-33. PubMed ID: 19739612
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer and neoadjuvant therapy: any predictive marker?
Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
[TBL] [Abstract][Full Text] [Related]
3. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
4. Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid.
Teng PN; Hood BL; Sun M; Dhir R; Conrads TP
J Proteome Res; 2011 Mar; 10(3):1333-42. PubMed ID: 21142074
[TBL] [Abstract][Full Text] [Related]
5. Changes in protein expression after neoadjuvant use of aromatase inhibitors in primary breast cancer: a proteomic approach to search for potential biomarkers to predict response or resistance.
Yiu CC; Sasano H; Ono K; Chow LW
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S79-89. PubMed ID: 20374034
[TBL] [Abstract][Full Text] [Related]
6. The evolving role of proteomics in the early detection of breast cancer.
Pawlik TM; Kuerer HM
Int J Fertil Womens Med; 2005; 50(5 Pt 1):212-6. PubMed ID: 16468471
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
[TBL] [Abstract][Full Text] [Related]
8. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
9. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients.
Bae SM; Lee CH; Cho YL; Nam KH; Kim YW; Kim CK; Han BD; Lee YJ; Chun HJ; Ahn WS
Gynecol Oncol; 2005 Oct; 99(1):26-35. PubMed ID: 16051329
[TBL] [Abstract][Full Text] [Related]
10. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.
Perera CN; Spalding HS; Mohammed SI; Camarillo IG
Exp Biol Med (Maywood); 2008 Jun; 233(6):708-20. PubMed ID: 18408141
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
12. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
13. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.
Alfonso P; Núñez A; Madoz-Gurpide J; Lombardia L; Sánchez L; Casal JI
Proteomics; 2005 Jul; 5(10):2602-11. PubMed ID: 15924290
[TBL] [Abstract][Full Text] [Related]
14. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
[TBL] [Abstract][Full Text] [Related]
15. Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy.
Diallo-Danebrock R; Ting E; Gluz O; Herr A; Mohrmann S; Geddert H; Rody A; Schaefer KL; Baldus SE; Hartmann A; Wild PJ; Burson M; Gabbert HE; Nitz U; Poremba C
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):488-97. PubMed ID: 17255270
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer.
Burcombe R; Wilson GD; Dowsett M; Khan I; Richman PI; Daley F; Detre S; Makris A
Breast Cancer Res; 2006; 8(3):R31. PubMed ID: 16790076
[TBL] [Abstract][Full Text] [Related]
17. Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistance.
Besada V; Diaz M; Becker M; Ramos Y; Castellanos-Serra L; Fichtner I
Proteomics; 2006 Feb; 6(3):1038-48. PubMed ID: 16385476
[TBL] [Abstract][Full Text] [Related]
18. Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery.
Kuerer HM; Goldknopf IL; Fritsche H; Krishnamurthy S; Sheta EA; Hunt KK
Cancer; 2002 Dec; 95(11):2276-82. PubMed ID: 12436432
[TBL] [Abstract][Full Text] [Related]
19. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
Holm C; Rayala S; Jirström K; Stål O; Kumar R; Landberg G
J Natl Cancer Inst; 2006 May; 98(10):671-80. PubMed ID: 16705121
[TBL] [Abstract][Full Text] [Related]
20. Use of serological proteomic methods to find biomarkers associated with breast cancer.
Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R
Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
